pubrio
Dizal Pharmaceutical

Dizal Pharmaceutical

China · Biotechnology Research

Biotechnology

Health, Wellness And Fitness

Biotechnology Research

Dizal Pharmaceutical Co., Ltd (Ticker: 688192 ) is a commercial stage biopharmaceutical company. At Dizal we aspire to discover and develop differentiated therapeutics for the treatment of cancer and immunological diseases. Building on our extensive expertise in translational science and molecular design, we have established an internationally competitive portfolio of five clinical-stage assets with two leading assets in global pivotal studies and one already approved.

Company Insights
Company Overview

2017

Founded

Biotechnology Research

Industry

China

Location

2,713,219

Ranking

200 employees

Size

Similar Companies
Similiar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Dizal Pharmaceutical

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Talk to Our Team
Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

Call Center

85259256922

Our Location

15th Floor ADGM Square, UAE

Social Network

© Pubrio 2026